News

Our CEO, Dr Peter A Milligan, has been interviewed by the Pharma Tech Outlook magazine. Read more about how we change the model informed drug development landscape of the pharmaceutical industry with

We are honoured that Pharmetheus has been listed as one of the top 10 pharma analytics companies in Europe by the Pharma Tech Outlook magazine for our Model Informed Drug Development consulting

We are present at the American Society of Hematology Annual Meeting & Exposition 2020. On Saturday, December 5, Daniel Röshammar will present on age and body weight adjusted dosing of dabigatran etexilate in children

We are advancing model informed drug development. In this video, Peter A Milligan describes our framework and some benefits of adopting these solutions across the project portfolio in terms of improved decision making, efficiency

We have been in the business for 8 years now. In this video Elodie Plan and Marie Sandström explain who we are and where we are heading.

We are happy to have Fanny onboard as a MIDD consultant. Her research experience includes PK/PD modeling and simulations of preclinical and clinical data in oncology. Fanny will first work from her

See the poster presentation of Population RTTE analysis of exacerbations in asthma patients by our MIDD Consultant Robin Svensson, presented at the American Conference on Pharmacometrics, November 2020

We are happy to have Andrea onboard as a MIDD consultant. Her research experience, from academia as well as pharmaceutical industry, includes PK/PD modeling and simulations in different therapeutic areas and concentration-QT analysis. Andrea will work from our Basel office in Switzerland. See her bio here